National Biodefense Science Board Public Teleconference, 22693 [2021-08951]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 81 / Thursday, April 29, 2021 / Notices
For the
latest information regarding the
meeting, including its start time and the
agenda, please access the ACCV
website: https://www.hrsa.gov/advisorycommittees/vaccines/meetings.html.
SUPPLEMENTARY INFORMATION:
Correction
In the Federal Register of January 28,
2021, FR Doc. 2021–01879, page 7402,
column 3, section 1, paragraph 2,
correct the DATES caption to read:
DATES: ACCV meetings will be held on:
• March 4, 2021, 10:00 a.m. Eastern
Time (ET)–4:00 p.m. ET;
• June 18, 2021, 10:00 a.m. ET–4:00
p.m. ET;
• September 2, 2021, 10:00 a.m. ET–
4:00 p.m. ET;
• December 2, 2021, 10:00 a.m. ET–
4:00 p.m. ET.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2021–08942 Filed 4–28–21; 8:45 am]
BILLING CODE 4165–15–P
Office of the Assistant
Secretary for Preparedness and
Response (ASPR), Department of Health
and Human Services (HHS).
ACTION: Notice.
The National Biodefense
Science Board (NBSB) provides expert
advice and guidance on scientific,
technical, and other matters of special
interest to the Department regarding
current and future chemical, biological,
nuclear, and radiological agents,
whether naturally occurring, accidental,
or deliberate.
DATES: The May 26, 2021, public
teleconference will include a general
discussion of strategic priorities for
public health and medical preparedness
and a possible vote on
recommendations. A more detailed
agenda will be available on the NBSB
meeting website https://www.phe.gov/
nbsb.
SUMMARY:
Members of the public may
attend the meeting via a toll-free call-in
phone number or Web-ex enabled
teleconference, which will be posted on
https://www.phe.gov/nbsb. Members of
the public may provide written
comments for consideration by the
NBSB at any time via email to NBSB@
hhs.gov. If such comments are specific
to the agenda for the current meeting,
please use ‘‘NBSB Public Comment for
jbell on DSKJLSW7X2PROD with NOTICES
Jkt 253001
The
National Biodefense Science Board
(NBSB) is authorized under Section
319M of the Public PHS Act, as added
by Section 402 of the Pandemic and AllHazards Preparedness Act of 2006 and
amended by Section 404 of the
Pandemic and All-Hazards
Preparedness Reauthorization Act. The
Board is governed by the Federal
Advisory Committee Act (5 U.S.C.
App.), which sets forth standards for the
formation and use of advisory
committees.
SUPPLEMENTARY INFORMATION:
BILLING CODE 4150–37–P
AGENCY:
18:32 Apr 28, 2021
CAPT Christopher L. Perdue, MD, MPH,
Executive Director, National Advisory
Committees; NBSB Designated Federal
Officer, Washington, DC, Office NBSB@
hhs.gov, (202) 401–5837.
[FR Doc. 2021–08951 Filed 4–28–21; 8:45 am]
National Biodefense Science Board
Public Teleconference
VerDate Sep<11>2014
FOR FURTHER INFORMATION CONTACT:
Nikki Bratcher-Bowman,
Acting Assistant Secretary for Preparedness
and Response.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ADDRESSES:
05/26/2021 in the subject line. Members
of the public are encouraged to provide
additional comments after the meeting
as well.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Nursing Research.
The meeting will be open to the
public as indicated below via videocast.
The URL link to this meeting is https://
videocast.nih.gov/watch=41947.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
22693
Name of Committee: National Advisory
Council for Nursing Research.
Date: May 18, 2021.
Open: 10:30 a.m. to 3:15 p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, One Democracy Plaza,
Bethesda, MD 20892, https://
videocast.nih.gov/watch=41947 (Virtual
Meeting).
Closed: 3:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Nursing
Research, National Institutes of Health, 6701
Democracy Boulevard, One Democracy Plaza,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan E. Old, Ph.D.,
Acting Deputy Director, National Institute of
Nursing Research, 31 Center Drive, Room
5B05, Bethesda, MD 20892, 301.496.7291,
oldse@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.ninr.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: April 23, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–08887 Filed 4–28–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Division of Intramural
Research Board of Scientific Counselors,
NIAID.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
National Institute of Allergy and
Infectious Diseases, including
consideration of personnel
qualifications and performance, and the
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 86, Number 81 (Thursday, April 29, 2021)]
[Notices]
[Page 22693]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08951]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Biodefense Science Board Public Teleconference
AGENCY: Office of the Assistant Secretary for Preparedness and Response
(ASPR), Department of Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The National Biodefense Science Board (NBSB) provides expert
advice and guidance on scientific, technical, and other matters of
special interest to the Department regarding current and future
chemical, biological, nuclear, and radiological agents, whether
naturally occurring, accidental, or deliberate.
DATES: The May 26, 2021, public teleconference will include a general
discussion of strategic priorities for public health and medical
preparedness and a possible vote on recommendations. A more detailed
agenda will be available on the NBSB meeting website https://www.phe.gov/nbsb.
ADDRESSES: Members of the public may attend the meeting via a toll-free
call-in phone number or Web-ex enabled teleconference, which will be
posted on https://www.phe.gov/nbsb. Members of the public may provide
written comments for consideration by the NBSB at any time via email to
[email protected]. If such comments are specific to the agenda for the
current meeting, please use ``NBSB Public Comment for 05/26/2021 in the
subject line. Members of the public are encouraged to provide
additional comments after the meeting as well.
FOR FURTHER INFORMATION CONTACT: CAPT Christopher L. Perdue, MD, MPH,
Executive Director, National Advisory Committees; NBSB Designated
Federal Officer, Washington, DC, Office [email protected], (202) 401-5837.
SUPPLEMENTARY INFORMATION: The National Biodefense Science Board (NBSB)
is authorized under Section 319M of the Public PHS Act, as added by
Section 402 of the Pandemic and All-Hazards Preparedness Act of 2006
and amended by Section 404 of the Pandemic and All-Hazards Preparedness
Reauthorization Act. The Board is governed by the Federal Advisory
Committee Act (5 U.S.C. App.), which sets forth standards for the
formation and use of advisory committees.
Nikki Bratcher-Bowman,
Acting Assistant Secretary for Preparedness and Response.
[FR Doc. 2021-08951 Filed 4-28-21; 8:45 am]
BILLING CODE 4150-37-P
